This article is more than 5 years old. Information may no longer be current.

EOS Imaging receives FDA clearance for Micro Dose

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

EOS Imaging recently announced that the FDA has cleared the Micro Dose feature for pediatric imaging.

According to initial study results presented at the French Society of Radiology’s annual meeting in 2013 and the Radiological Society of North America’s annual meeting in 2014, the Micro Dose feature generates dosage levels equivalent to a week of naturally-occurring background radiation in pediatric patients receiving 2-D and 3-D follow-up examinations.

Micro Dose is meant to address an important medical need for pediatric patients who are sensitive to adverse effects associated with excessive exposure to radiation. This is particularly important in pediatric patients with scoliosis, who require frequent imaging sessions to track treatment progression that can, in turn, increase the risk of radiation-induced cancer later in life, according to a company press release.

Reference: www.eos-imaging.com.